Skip to content

Adverse events of standardized regimens of corticosteroids for prophylaxis and treatment of nerve function impairment in leprosy: results from the ‘TRIPOD’ trials

J. H. Richardus, S. G. Withington, A.M. Anderson, R. P. Croft, P. G. Nicholls, W.H. van Brakel, W.C.S. Smith

Reactions in leprosy patients causing acute nerve function impairment (NFI) can often be treated successfully with corticosteriods. Treatment with corticosteriods in leprosy control programmes is increasingly being provided under field conditions, often by paramedical workers.

Related work

  • Long Term Collaboration with Netherlands Leprosy Relief

    • Institute
    • Project

    In a long-term collaboration, KIT Royal Tropical Institute and the Netherlands Leprosy Relief (NLR) have been working to reduce leprosy, whilst improving methods for its evaluation and study. This has resulted in significant research contribution and global policy setting, as well as country-level improvements in leprosy detection and control. Furthering the agenda in global leprosy […]

  • The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline

    • Institute
    • Publication

    Leprosy is known for the neuropathy it causes. Different methods have been used to detect leprosy-related nerve function impairment (NFI).More sophisticated methods for assessing nerve function such as vibrometry, laser Doppler flowmetry and thermal threshold testing have been shown to detect different modalities of leprous neuropathy. However, it is not known which of these testing […]

  • Treatment with corticosteroids of long-standing nerve function impairment in leprosy: a randomized controlled trial (TRIPOD 3)

    • Institute
    • Publication

    Nerve Function Impairment (NFI) in leprosy patients may lead to severe disabilities, such as muscle paralysis of face, hands and feet, and chronic plantar and palmar ulceration. For many years, the mainstay of treatment of NFI of less than 6 months duration, in particular in the presence of clinically manifest type 1 reaction, has been […]